Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study). (Record no. 22039055)

MARC details
000 -LEADER
fixed length control field 02261 a2200601 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516105706.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201302s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1549-490X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1634/theoncologist.2011-0467
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Pautier, Patricia
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20130211
245 00 - TITLE STATEMENT
Title Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study).
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The oncologist
Date of publication, distribution, etc. 2012
300 ## - PHYSICAL DESCRIPTION
Extent 1213-20 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Deoxycytidine
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Docetaxel
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element France
General subdivision epidemiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Granulocyte Colony-Stimulating Factor
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leiomyosarcoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lenograstim
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Metastasis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Proteins
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Taxoids
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Uterine Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gemcitabine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Floquet, Anne
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Penel, Nicolas
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Piperno-Neumann, Sophie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Isambert, Nicolas
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rey, Annie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bompas, Emmanuelle
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cioffi, Angela
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Delcambre, Corinne
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cupissol, Didier
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Collin, Françoise
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Blay, Jean-Yves
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jimenez, Marta
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Duffaud, Florence
773 0# - HOST ITEM ENTRY
Title The oncologist
Related parts vol. 17
-- no. 9
-- p. 1213-20
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1634/theoncologist.2011-0467">https://doi.org/10.1634/theoncologist.2011-0467</a>
Public note Available from publisher's website

No items available.